Farrah Short

Special Counsel vCard


  • University of Pennsylvania Law School (JD)
  • Wellesley College (BA)

Bar Admissions

  • District of Columbia
  • New York

Farrah advises on all aspects of antitrust and competition law, including merger review, competitor collaborations, government investigations, private class action litigation, and general antitrust compliance.

Farrah specializes in counseling clients through the Hart-Scott-Rodino (HSR) merger review process at the U.S. Federal Trade Commission and the U.S. Department of Justice, including responding to Second Requests and providing substantive antitrust risk analysis for strategic acquisitions. She has obtained antitrust clearance for major, multi-billion dollar transactions in a variety of industries.  Farrah also regularly advises on HSR reporting triggers for securities investors and provides strategic advice for non-reportable transactions with significant competitive implications.

She also has significant experience counseling clients on a wide range of other antitrust compliance issues, including information exchanges, competitor collaborations, joint ventures, licensing deals, exclusive dealings, and the creation of internal antitrust compliance programs.  In addition, Farrah represents clients in state antitrust investigations, and provides guidance on navigating ex-U.S. merger control requirements.

Outside of her antitrust practice, Farrah serves as chief outside counsel to the National Network to End Domestic Violence.  She also actively supports the firm’s pro bono program, representing indigent clients in immigration matters, including successful asylum and U visa applications. She previously served as chief outside counsel for a nonprofit that provides need-based education scholarships for the families of U.S. military personnel.

Prior to her legal career, Farrah was a program associate for the launch of the Women and Public Policy Program at Harvard’s Kennedy School.

Representative Merger Review Matters

  • Secured antitrust clearance, without an extended investigation, for a $1.3 billion pharmaceutical merger.
  • Obtained early termination of the HSR waiting period for an exclusive license pharmaceutical deal in a concentrated market.
  • Cleared the HSR process for a wireless technology asset acquisition.
  • Represented retail pharmacy in $2.7 billion acquisition of competitor.
  • Counseled client through merger investigation for acquisition of an overbuilt cable system.

Recognitions & Awards

  • Washington D.C. Super Lawyers: Rising Star - Antitrust Litigation (2015)
  • City Year Idealist of the Year (2015)